4.2 Article

Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal Doxorubicin for brain drug delivery with a post-insertion approach

Journal

IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
Volume 25, Issue 3, Pages 302-312

Publisher

MASHHAD UNIV MED SCIENCES
DOI: 10.22038/IJBMS.2022.60306.13369

Keywords

Biodistribution; Blood-brain barrier; Brain drug delivery; Glutathione; Liposome; Post-insertion

Funding

  1. Biotechnology Research Center and Nanotechnology Research Center, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran

Ask authors/readers for more resources

This study developed PEGylated nanoliposomal Doxorubicin particles covalently attached to glutathione using the post-insertion technique. Compared with the pre-insertion method, the post-insertion approach was found to be simpler, faster, and more cost-effective, making it suitable for large-scale production. The results showed that nanocarriers with 40 times fewer GSH micelles significantly enhanced blood-brain barrier penetrance.
Objective(s): Brain cancer treatments have mainly failed due to their inability to cross the bloodbrain barrier. Several studies have confirmed the presence of glutathione (GSH) receptors on BBB's surface, as a result, products like 2B3-101, which contain over 5% pre-inserted GSH PEGylated liposomal Doxorubicin, are being tested in clinical trials. Here we conducted the PEGylated nanoliposomal Doxorubicin particles that are covalently attached to the glutathione using the postinsertion technique. Compared with the pre-insertion approach, the post-insertion method is notably simpler, faster, and more cost-effective, making it ideal for large-scale pharmaceutical manufacturing. Materials and Methods: The ligands of the DSPE PEG(2000) Maleimide-GSH were introduced in the amounts of 25, 50, 100, 200, and 400 on the available Caelyx. Following physicochemical evaluations, animal experiments such as biodistribution, fluorescence microscopy, and pharmacokinetics were done. Results: In comparison with Caelyx, the 200L and 400L treatment arms were the most promising formulations. We showed that nanocarriers containing 40 times fewer GSH micelles than 2B3-101 significantly increased blood-brain barrier penetrance. Due to the expressed GSH receptors on tissues as an endogenous antioxidant, Doxorubicin will likely concentrate in the liver, spleen, heart, and lung in comparison with Caelyx, according to other tissue analyses. Conclusion: The post-insertion technique was found a successful approach with more pharmaceutical aspects for large-scale production. Moreover, further investigations are highly recommended to determine the efficacy of 5% post-inserted GSH targeted nanoliposomes versus 2B3-101 as a similar formulation with a different preparation method.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available